SecBot SecBot

Clinical Trial Modernization Act

H.R. 3521 Rep. Raul Ruiz (D-CA-25) In committee
  1. Introduced May 20
  2. Committee May 20
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, May 20, 2025Next: House vote
525d ago May 20, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
4companies, 19 filings
Member trades
9trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

4 companies
Companies by sector
Biotech & Pharma 3Medical Devices & Healthcare 1
Search all 4 companies, their asks and price moves Subscribe

Summary

Clinical Trial Modernization Act

Full summary4 paragraphs

This bill authorizes a grant program and provides certain exemptions to support the participation of individuals in clinical trials.

Specifically, the bill authorizes a grant program to support outreach, education, and recruitment efforts for clinical trials that may benefit certain underrepresented populations or communities in need, such as rural or tribal areas.

The bill also exempts from anti-kickback laws for federal health care programs (1) remuneration that is offered to cover participants' expenses to participate in clinical trials, (2) the provision of free digital health technologies to support participation of underrepresented populations in clinical trials, and (3) payment for participants' cost-sharing obligations in relation to clinical trials.

Finally, the bill exempts up to $2,000 in remuneration that is received for participating in a clinical trial from income tax.

Library of Congress summary, May 20, 2025

Summary versions
  • Introduced in HouseMay 20, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.